The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies
出版年份 2021 全文链接
标题
The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-05-05
DOI
10.3389/fonc.2021.673506
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I Study of Escalating Doses of Carfilzomib with HyperCVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia
- (2021) Brian A. Jonas et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop
- (2021) Lucine Fahy et al. Blood Advances
- miRNAs as Influencers of Cell–Cell Communication in Tumor Microenvironment
- (2020) Ilaria Conti et al. Cells
- Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
- (2020) Monika Zajkowska et al. ACTA BIOCHIMICA POLONICA
- Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults
- (2020) Anand A. Patel et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity
- (2020) Mahdieh Mehrpouri et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Characterizing Lymphangiogenesis and Concurrent Inflammation in Adipose Tissue in Response to VEGF-D
- (2020) Adri Chakraborty et al. Frontiers in Physiology
- Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
- (2020) Lia Walcher et al. Frontiers in Immunology
- SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine
- (2020) Tamara Rothenburger et al. Communications Biology
- Targeting mTOR in Acute Lymphoblastic Leukemia
- (2019) Carolina Simioni et al. Cells
- Relapsed T Cell ALL: Current Approaches and New Directions
- (2019) Christine M. McMahon et al. Current Hematologic Malignancy Reports
- Inhibition of the PI3K/AKT signaling pathway sensitizes diffuse large B‑cell lymphoma cells to treatment with proteasome inhibitors via suppression of BAG3
- (2019) Ting Yuan et al. Oncology Letters
- Adrenergic Modulation of Hematopoiesis
- (2019) Georges J. M. Maestroni Journal of Neuroimmune Pharmacology
- Leukemia-derived exosomes and cytokines pave the way for entry into the brain
- (2019) Ichiko Kinjyo et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Knockdown of the CXCL12/CXCR7 chemokine pathway results in learning deficits and neural progenitor maturation impairment in mice
- (2019) Françoise Trousse et al. BRAIN BEHAVIOR AND IMMUNITY
- OBI-3424, a novel AKR1C3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL
- (2019) Kathryn Evans et al. CLINICAL CANCER RESEARCH
- Hematopoietic stem cells
- (2019) Zhenrui Li et al. CURRENT OPINION IN HEMATOLOGY
- Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
- (2019) Pawel Robak et al. Drugs in research & development
- Imaging and spatial analysis of hematopoietic stem cell niches
- (2019) Alvaro Gomariz et al. Annals of the New York Academy of Sciences
- Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer
- (2019) Bhagyashri Kulkarni et al. DRUG DISCOVERY TODAY
- HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia
- (2019) Valentina Griggio et al. HAEMATOLOGICA
- Overexpression of heme oxygenase‐1 in microenvironment mediates vincristine resistance of B‐cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion
- (2019) Kunlin Yu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-Leukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia
- (2019) Sankaranarayanan Kannan et al. MOLECULAR CANCER THERAPEUTICS
- NEW BIOMARKERS AND THERAPEUTIC STRATEGIES IN ACUTE LYMPHOBLASTIC LEUKEMIAS: RECENT ADVANCES
- (2019) Carolina Simioni et al. HEMATOLOGICAL ONCOLOGY
- T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7
- (2019) Anne Buffière et al. ONCOGENE
- Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer
- (2019) D. M. Valcourt et al. ANNALS OF BIOMEDICAL ENGINEERING
- Tumor angiogenesis: causes, consequences, challenges and opportunities
- (2019) Roberta Lugano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib
- (2019) Keith J. August et al. PEDIATRIC BLOOD & CANCER
- Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
- (2019) Lynn Jena et al. Drug Delivery and Translational Research
- Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes
- (2019) Lauren K. Meyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
- (2019) Joseph A. Clara et al. Nature Reviews Clinical Oncology
- Oxidative stress in normal hematopoietic stem cells and leukemia
- (2018) Azin Samimi et al. APMIS
- T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies
- (2018) Eduardo Vadillo et al. BLOOD REVIEWS
- Targeting the microenvironment in solid tumors
- (2018) Carmen Belli et al. CANCER TREATMENT REVIEWS
- Blood Development: Hematopoietic Stem Cell Dependence and Independence
- (2018) Elaine Dzierzak et al. Cell Stem Cell
- Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
- (2018) Carlyn Rose C. Tan et al. CLINICAL PHARMACOKINETICS
- Bortezomib in Kidney Transplant: Current Use and Perspectives
- (2018) Lucio R. Requiao-Moura et al. CURRENT DRUG METABOLISM
- Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
- (2018) Amnon Peled et al. CYTOKINE
- Characterization of a new B-ALL cell line with constitutional defect of the Notch signaling pathway
- (2018) Paul Takam Kamga et al. Oncotarget
- The safety of bortezomib for the treatment of multiple myeloma
- (2018) Guldane Cengiz Seval et al. Expert Opinion On Drug Safety
- Immune cell subset differentiation and tissue inflammation
- (2018) Pu Fang et al. Journal of Hematology & Oncology
- Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma
- (2018) I-Tao Huang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy
- (2018) Chulin Sha et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuing challenges and current issues in acute lymphoblastic leukemia
- (2017) Ankit Kansagra et al. LEUKEMIA & LYMPHOMA
- Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia
- (2017) Xin Du et al. Molecular Medicine Reports
- Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia
- (2017) Angela Maria Savino et al. Expert Review of Hematology
- The hypoxia signalling pathway in haematological malignancies
- (2017) Marta Irigoyen et al. Oncotarget
- Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
- (2017) Sirin Yonucu et al. PLoS Computational Biology
- CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ
- (2017) Frederick Allen et al. OncoImmunology
- Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines
- (2017) Kazuya Takahashi et al. PLoS One
- Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting
- (2016) Francesca Chiarini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- The role of bortezomib in the treatment of acute lymphoblastic leukemia
- (2016) Mohammad Faizan Zahid Future Oncology
- Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity
- (2016) Alice Melão et al. HAEMATOLOGICA
- Microenvironmental cues for T-cell acute lymphoblastic leukemia development
- (2016) Diana Passaro et al. IMMUNOLOGICAL REVIEWS
- Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway
- (2016) Annalisa Lonetti et al. Journal of Hematology & Oncology
- The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia
- (2016) Hongxia Chen et al. LEUKEMIA RESEARCH
- Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
- (2016) Franziska Scheibe et al. NEUROLOGY
- Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma
- (2016) Tapan M. Kadia et al. Expert Review of Hematology
- Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse
- (2016) Yusuke Higuchi et al. Cancer Genetics
- Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity
- (2016) Alice Melão et al. HAEMATOLOGICA
- AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia
- (2015) D. Moradi Manesh et al. BLOOD
- Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling
- (2015) Vincenzo Giambra et al. BLOOD
- CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance
- (2015) Lauren A. Pitt et al. CANCER CELL
- CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target
- (2015) Aparecida de Lourdes Perim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia
- (2015) Md Almamun et al. Epigenetics
- Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- (2015) João Kleber Novais Pereira et al. EUROPEAN JOURNAL OF CANCER
- Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia
- (2015) M T Witkowski et al. LEUKEMIA
- A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
- (2015) Lukas D. Wartman et al. LEUKEMIA & LYMPHOMA
- The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells
- (2015) Carolina Simioni et al. Oncotarget
- Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
- (2015) Alice Cani et al. Oncotarget
- Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect
- (2015) Nicolas Andre et al. Oncotarget
- Role of tumour angiogenesis in haematological malignancies
- (2015) M Medinger et al. SWISS MEDICAL WEEKLY
- Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation
- (2015) Carolina Simioni et al. Oncotarget
- Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways
- (2014) Dalila Naci et al. CELLULAR SIGNALLING
- The Role of Hypoxia and Exploitation of the Hypoxic Environment in Hematologic Malignancies
- (2014) Barbara Muz et al. MOLECULAR CANCER RESEARCH
- CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
- (2014) Roberto Würth et al. Frontiers in Cellular Neuroscience
- Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
- (2013) Jie Zou et al. Journal of Hematology & Oncology
- Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential
- (2013) L M Neri et al. LEUKEMIA
- Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment
- (2012) Olga Frolova et al. CANCER BIOLOGY & THERAPY
- Microenvironment-mediated resistance to anticancer therapies
- (2012) Oakley C Olson et al. CELL RESEARCH
- Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
- (2012) M. Shibuya JOURNAL OF BIOCHEMISTRY
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
- (2012) C Simioni et al. LEUKEMIA
- Endothelial and perivascular cells maintain haematopoietic stem cells
- (2012) Lei Ding et al. NATURE
- Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells
- (2011) A. H. Nwabo Kamdje et al. BLOOD
- Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia
- (2011) Sergej Konoplev et al. CANCER
- Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer
- (2011) L. Martinet et al. CANCER RESEARCH
- Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
- (2011) Yin Wang et al. Cell Stem Cell
- Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells
- (2011) A Dar et al. LEUKEMIA
- Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104
- (2011) Juliana Benito et al. PLoS One
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- CXCR7: a new SDF-1-binding receptor in contrast to normal CD34+ progenitors is functional and is expressed at higher level in human malignant hematopoietic cells
- (2010) Maciej Tarnowski et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The cancer stem cell paradigm: a new understanding of tumor development and treatment
- (2010) Johnathan D Ebben et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia
- (2010) George Deeb et al. LEUKEMIA RESEARCH
- Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
- (2010) Simón Méndez-Ferrer et al. NATURE
- Increased CCL2 and IL-8 in the bone marrow microenvironment in acute lymphoblastic leukemia
- (2010) Jaíra Ferreira de Vasconcellos et al. PEDIATRIC BLOOD & CANCER
- Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors Cyclopamine and IPI-926
- (2010) Tara L. Lin et al. PLoS One
- The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
- (2010) Alberto M. Martelli et al. Cancers
- Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
- (2009) A. K. Ghosh et al. BLOOD
- Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
- (2009) Gregg L. Semenza PHYSIOLOGY
- Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF- B and JNK/AP-1 pathways
- (2008) M. T. Scupoli et al. HAEMATOLOGICA
- Stem Cell Niche: Microenvironment and Beyond
- (2008) Jiwang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started